(Q44098314)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249693%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

title

Initial experience with bendamustine in patients with recurrent primary central nervous system lymphoma: a case report (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249693%20AND%20SRC:MED&resulttype=core&format=json

central nervous system lymphoma

20 January 2020

main subject

1 reference

primary central nervous system lymphoma

inferred from title

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249693%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Jaclyn J Renfrow

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249693%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Alisha Detroye

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249693%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Michael Chan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249693%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Thomas Ellis

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249693%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Kevin McMullen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249693%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Annette Johnson

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249693%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Ryan Mott

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249693%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Glenn J Lesser

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249693%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

publication date

17 January 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249693%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuro-Oncology

20 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249693%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

107

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249693%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249693%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

659-663

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249693%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11060-011-0788-x

20 January 2020

exact match

0 references

cites work

Decreasing incidence rates of primary central nervous system lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0788-X

Long-term outcome in PCNSL patients treated with high-dose methotrexate and deferred radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0788-X

Chemotherapy for primary central nervous system lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0788-X

High-dose methotrexate and rituximab with deferred radiotherapy for newly diagnosed primary B-cell CNS lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0788-X

Combined modality therapy for primary CNS lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0788-X

High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0788-X

RNA-mediated neurodegeneration in repeat expansion disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0788-X

Treatment of primary central nervous system lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0788-X

Salvage treatment with etoposide (VP-16), ifosfamide and cytarabine (Ara-C) for patients with recurrent primary central nervous system lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0788-X

Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0788-X

Response of relapsed or refractory primary central nervous system lymphoma (PCNSL) to topotecan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0788-X

Optimal use of bendamustine in chronic lymphocytic leukemia, non-Hodgkin lymphomas, and multiple myeloma: treatment recommendations from an international consensus panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0788-X

Regression of brain metastases from breast carcinoma after chemotherapy with bendamustine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0788-X

Bendamustine (Treanda) displays a distinct pattern of cytotoxicity and unique mechanistic features compared with other alkylating agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0788-X

Bendamustine is effective in p53-deficient B-cell neoplasms and requires oxidative stress and caspase-independent signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0788-X

Salvage therapy with single agent bendamustine for recurrent glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0788-X

Primary central nervous system lymphoma: a single-centre experience of 55 unselected cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0788-X

Salvage whole brain radiotherapy for recurrent or refractory primary CNS lymphoma

21 January 2018

1 reference

12 December 2020

Primary central nervous system lymphoma

1 reference

12 December 2020

Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315

1 reference

12 December 2020

Chemotherapy without radiation therapy as initial treatment for primary CNS lymphoma in older patients

1 reference

12 December 2020

Therapeutic management of refractory or relapsed primary central nervous system lymphomas.

1 reference

12 December 2020

Salvage therapy with temozolomide in an immunocompetent patient with primary brain lymphoma

1 reference

12 December 2020

10.1007/S11060-011-0788-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249693%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference